This Metric Says You Are Smart to Sell Lexicon Pharmaceuticals, Inc. (LXRX)

Is Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) the right investment to pursue these days? The smart money is taking a pessimistic view. The number of long hedge fund bets dropped by 3 lately.

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

In today’s marketplace, there are tons of metrics shareholders can use to analyze stocks. A pair of the most under-the-radar are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite investment managers can trounce their index-focused peers by a very impressive amount (see just how much).

Just as important, positive insider trading sentiment is a second way to parse down the stock market universe. As the old adage goes: there are a number of incentives for an insider to cut shares of his or her company, but just one, very clear reason why they would behave bullishly. Many empirical studies have demonstrated the useful potential of this tactic if “monkeys” know where to look (learn more here).

With these “truths” under our belt, we’re going to take a glance at the latest action surrounding Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX).

How have hedgies been trading Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)?

At the end of the fourth quarter, a total of 7 of the hedge funds we track were long in this stock, a change of -30% from one quarter earlier. With hedge funds’ capital changing hands, there exists an “upper tier” of notable hedge fund managers who were increasing their stakes substantially.

Of the funds we track, Chuck Royce’s Royce & Associates had the most valuable position in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), worth close to $9.8 million, accounting for less than 0.1%% of its total 13F portfolio. Sitting at the No. 2 spot is Perceptive Advisors, managed by Joseph Edelman, which held a $5.3 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Some other peers that hold long positions include Steven Cohen’s SAC Capital Advisors, SAC Subsidiary’s Sigma Capital Management and D. E. Shaw’s D E Shaw.

Since Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) has witnessed bearish sentiment from the entirety of the hedge funds we track, it’s easy to see that there was a specific group of hedge funds that elected to cut their full holdings last quarter. At the top of the heap, Israel Englander’s Millennium Management dropped the largest investment of all the hedgies we watch, comprising close to $0.5 million in stock.. Wayne Holman’s fund, Ridgeback Capital Management, also sold off its stock, about $0.2 million worth. These bearish behaviors are important to note, as total hedge fund interest was cut by 3 funds last quarter.

How are insiders trading Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)?

Insider buying is best served when the company we’re looking at has seen transactions within the past six months. Over the last 180-day time frame, Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) has seen 2 unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX). These stocks are Nektar Therapeutics (NASDAQ:NKTR), PDL BioPharma Inc. (NASDAQ:PDLI), Sarepta Therapeutics Inc (NASDAQ:SRPT), VIVUS, Inc. (NASDAQ:VVUS), and Santarus, Inc. (NASDAQ:SNTS). This group of stocks are in the biotechnology industry and their market caps are similar to LXRX’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Nektar Therapeutics (NASDAQ:NKTR) 9 0 0
PDL BioPharma Inc. (NASDAQ:PDLI) 14 0 0
Sarepta Therapeutics Inc (NASDAQ:SRPT) 16 0 1
VIVUS, Inc. (NASDAQ:VVUS) 19 0 0
Santarus, Inc. (NASDAQ:SNTS) 16 1 12

With the returns demonstrated by our research, everyday investors must always monitor hedge fund and insider trading activity, and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is an important part of this process.

Click here to learn why you should track hedge funds

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!